Group 1 - The core viewpoint of the article is that Chengzhi Co., Ltd. (000990.SZ) has indicated on its investor interaction platform that its D-ribose can serve as a starting material for certain innovative drugs [1] Group 2 - The company is involved in the pharmaceutical industry, specifically in the production of raw materials for innovative drug development [1]